Pædiatrisk hypertension Der er begrænset dokumentation for losartans sikkerhed og virkning hos børn og unge i alderen 6- 16 år mht. behandling for hypertension (se pkt.
Pediatric hypertension There are limited data on the efficacy and safety of losartan in children and adolescents aged 6-16 years old for the treatment of hypertension (see 5.1: